Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Besse S"" wg kryterium: Autor


Tytuł :
Efficacy of Targeted Radionuclide Therapy Using [ I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.
Autorzy :
Akil H; INSERM U1240, University of Clermont Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France.; CNRS 7276, INSERM U1262, 2 rue du Pr Descottes, 87025 Limoges, France.
Quintana M; INSERM U1240, University of Clermont Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France.
Raymond JH; INSERM U1021, Normal and Pathological Development of Melanocytes, Institut Curie, PSL Research University, Campus Universitaire, 91898 Orsay, France.; Campus Universitaire, University Paris-Sud, University Paris-Saclay, CNRS UMR3347, 91898 Orsay, France.; Equipes Labellisées-Ligue Contre le Cancer, Campus Universitaire, 91898 Orsay, France.
Billoux T; Cirmen, Centre Jean Perrin, 58 rue Montalembert, 63000 Clermont-Ferrand, France.
Benboubker V; INSERM U1240, University of Clermont Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France.
Besse S; INSERM U1240, University of Clermont Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France.
Auzeloux P; INSERM U1240, University of Clermont Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France.
Delmas V; INSERM U1021, Normal and Pathological Development of Melanocytes, Institut Curie, PSL Research University, Campus Universitaire, 91898 Orsay, France.; Campus Universitaire, University Paris-Sud, University Paris-Saclay, CNRS UMR3347, 91898 Orsay, France.; Equipes Labellisées-Ligue Contre le Cancer, Campus Universitaire, 91898 Orsay, France.
Petit V; INSERM U1021, Normal and Pathological Development of Melanocytes, Institut Curie, PSL Research University, Campus Universitaire, 91898 Orsay, France.; Campus Universitaire, University Paris-Sud, University Paris-Saclay, CNRS UMR3347, 91898 Orsay, France.; Equipes Labellisées-Ligue Contre le Cancer, Campus Universitaire, 91898 Orsay, France.
Larue L; INSERM U1021, Normal and Pathological Development of Melanocytes, Institut Curie, PSL Research University, Campus Universitaire, 91898 Orsay, France.; Campus Universitaire, University Paris-Sud, University Paris-Saclay, CNRS UMR3347, 91898 Orsay, France.; Equipes Labellisées-Ligue Contre le Cancer, Campus Universitaire, 91898 Orsay, France.
D'Incan M; INSERM U1240, University of Clermont Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France.; Department of Dermatology and Oncodermatology, CHU Estaing, 1 Place Aubrac, 63000 Clermont-Ferrand, France.
Degoul F; INSERM U1240, University of Clermont Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France.; CNRS 6293 INSERM U1103, University of Clermont Auvergne, 28, Place Henri Dunant, 63000 Clermont-Ferrand, France.
Rouanet J; INSERM U1240, University of Clermont Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France.; Department of Dermatology and Oncodermatology, CHU Estaing, 1 Place Aubrac, 63000 Clermont-Ferrand, France.
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2021 Mar 20; Vol. 13 (6). Date of Electronic Publication: 2021 Mar 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Fanconi anemia A protein participates in nucleolar homeostasis maintenance and ribosome biogenesis.
Autorzy :
Gueiderikh A; CNRS-UMR9019, Équipe labellisée 'La Ligue contre le Cancer,' 94805 Villejuif, France.; Gustave Roussy Cancer Center, 94805 Villejuif, France.; Université Paris-Saclay-Paris Sud, Orsay, France.
Maczkowiak-Chartois F; CNRS-UMR9019, Équipe labellisée 'La Ligue contre le Cancer,' 94805 Villejuif, France.; Gustave Roussy Cancer Center, 94805 Villejuif, France.; Université Paris-Saclay-Paris Sud, Orsay, France.
Rouvet G; CNRS-UMR9019, Équipe labellisée 'La Ligue contre le Cancer,' 94805 Villejuif, France.; Gustave Roussy Cancer Center, 94805 Villejuif, France.; Université Paris-Saclay-Paris Sud, Orsay, France.
Souquère-Besse S; Gustave Roussy Cancer Center, 94805 Villejuif, France.; Université Paris-Saclay-Paris Sud, Orsay, France.; CNRS-UMS3655, 94805 Villejuif, France.
Apcher S; Gustave Roussy Cancer Center, 94805 Villejuif, France.; Université Paris-Saclay-Paris Sud, Orsay, France.; INSERM-UMR1015, 94805 Villejuif, France.
Diaz JJ; Université Lyon, Université Claude Bernard Lyon 1, Inserm 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373 Lyon cedex 08, France.
Rosselli F; CNRS-UMR9019, Équipe labellisée 'La Ligue contre le Cancer,' 94805 Villejuif, France. .; Gustave Roussy Cancer Center, 94805 Villejuif, France.; Université Paris-Saclay-Paris Sud, Orsay, France.
Pokaż więcej
Źródło :
Science advances [Sci Adv] 2021 Jan 01; Vol. 7 (1). Date of Electronic Publication: 2021 Jan 01 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Distinction between arterial and venous occlusion with tissue oxygen pressure in a porcine fascio-cutaneous flap model.
Autorzy :
Lartizien R; Service de Chirurgie Maxillo-faciale, Centre Hospitalier d'Annecy Genevois, Epagny Metz-Tessy, France.; INSERM-UGA U1209; CNRS UMR5309, Institute for Advanced Biosciences, Grenoble, France.
Besse S; Service de Chirurgie Maxillo-faciale, Centre Hospitalier d'Annecy Genevois, Epagny Metz-Tessy, France.
Bettega P; Laboratoire d'économie appliquée de Grenoble, Saint-Martin-d'Hères, France.
Zaccaria I; Service de Chirurgie Maxillo-faciale, Centre Hospitalier d'Annecy Genevois, Epagny Metz-Tessy, France.
Planat-Chrétien A; Université Grenoble Alpes, CEA, LETI, DTBS, LS2P, Grenoble, France.
Berger M; Université Grenoble Alpes, CEA, LETI, DTBS, LS2P, Grenoble, France.
Henry M; INSERM-UGA U1209; CNRS UMR5309, Institute for Advanced Biosciences, Grenoble, France.
Coll JL; INSERM-UGA U1209; CNRS UMR5309, Institute for Advanced Biosciences, Grenoble, France.
Bettega G; Service de Chirurgie Maxillo-faciale, Centre Hospitalier d'Annecy Genevois, Epagny Metz-Tessy, France.; INSERM-UGA U1209; CNRS UMR5309, Institute for Advanced Biosciences, Grenoble, France.
Pokaż więcej
Źródło :
Microsurgery [Microsurgery] 2020 Nov; Vol. 40 (8), pp. 881-885. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy.
Autorzy :
Rouanet J; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France. .; Department of Dermatology and Oncodermatology, CHU Estaing, 1 place Lucie et Raymond Aubrac, 63000, Clermont-Ferrand, France. .; Centre Jean Perrin, 58, rue Montalembert, 63011, Clermont-Ferrand, France. .
Benboubker V; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.; Department of Histocompatibility and Immunogenetics, CHU Gabriel Montpied, 58 rue Montalembert, 63000, Clermont-Ferrand, France.
Akil H; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
Hennino A; UMR INSERM 1052 CNRS 5286 CRCL, 28 rue Laennec, 69008, Lyon, France.
Auzeloux P; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
Besse S; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
Pereira B; Biostatistics Unit, DRCI, CHU Gabriel Montpied, 58 rue Montalembert, 63000, Clermont-Ferrand, France.
Delorme S; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
Mansard S; Department of Dermatology and Oncodermatology, CHU Estaing, 1 place Lucie et Raymond Aubrac, 63000, Clermont-Ferrand, France.
D'Incan M; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.; Department of Dermatology and Oncodermatology, CHU Estaing, 1 place Lucie et Raymond Aubrac, 63000, Clermont-Ferrand, France.
Degoul F; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
Rouzaire PO; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.; Department of Histocompatibility and Immunogenetics, CHU Gabriel Montpied, 58 rue Montalembert, 63000, Clermont-Ferrand, France.
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Oct; Vol. 69 (10), pp. 2075-2088. Date of Electronic Publication: 2020 May 23.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents, Immunological/*therapeutic use
Immunotherapy/*methods
Iodine Radioisotopes/*therapeutic use
Melanoma, Experimental/*immunology
Melanoma, Experimental/*therapy
Radiation Tolerance/*drug effects
Animals ; Combined Modality Therapy ; Melanoma, Experimental/pathology ; Mice ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
Spectral Properties and Physical Extent of Pyroclastic Deposits on Mercury: Variability Within Selected Deposits and Implications for Explosive Volcanism.
Autorzy :
Besse, S.
Doressoundiram, A.
Barraud, O.
Griton, L.
Cornet, T.
Muñoz, C.
Varatharajan, I.
Helbert, J.
Pokaż więcej
Temat :
VOLCANIC ash, tuff, etc.
PLANETARY volcanism
GEOLOGY of Mercury
GRAIN size
INFRARED spectra
SURFACE of Mercury
Źródło :
Journal of Geophysical Research. Planets; May2020, Vol. 125 Issue 5, p1-13, 13p
Czasopismo naukowe
Tytuł :
[Geriatric medicine : Update 2019].
Autorzy :
Heck GM; Service de gériatrie et de réadaptation gériatrique, CHUV, 1011 Lausanne.
Lajoso S; Service de gériatrie et de réadaptation gériatrique, CHUV, 1011 Lausanne.
Schneider R; Service de gériatrie et de réadaptation gériatrique, CHUV, 1011 Lausanne.
Puttalaz P; Service de gériatrie et de réadaptation gériatrique, CHUV, 1011 Lausanne.
Cochet C; Service de gériatrie et de réadaptation gériatrique, CHUV, 1011 Lausanne.
Gagliano MA; Service de gériatrie et de réadaptation gériatrique, CHUV, 1011 Lausanne.
Besse S; Service de gériatrie et de réadaptation gériatrique, CHUV, 1011 Lausanne.
Costa AD; Service de gériatrie et de réadaptation gériatrique, CHUV, 1011 Lausanne.
Musumeci V; Service de gériatrie et de réadaptation gériatrique, CHUV, 1011 Lausanne.
Nguyen S; Service de gériatrie et de réadaptation gériatrique, CHUV, 1011 Lausanne.
Büla C; Service de gériatrie et de réadaptation gériatrique, CHUV, 1011 Lausanne.
Pokaż więcej
Transliterated Title :
Gériatrie.
Źródło :
Revue medicale suisse [Rev Med Suisse] 2020 Jan 15; Vol. 16 (676-7), pp. 37-40.
Typ publikacji :
Journal Article
MeSH Terms :
Antipsychotic Agents*
Delirium*
Dementia*
Diabetes Mellitus, Type 2*
Geriatrics*/trends
Aged ; Aged, 80 and over ; Humans ; Meta-Analysis as Topic
Czasopismo naukowe
Tytuł :
Preliminary evaluations of PSMA-targeted NIR upconverting nanoparticles for dual scintigraphic/fluorescence-guided surgery in prostate cancer.
Autorzy :
CORDONNIER, A.
Chezal, J.-M.
Besse, S.
BRIAT, A.
Degoul, F.
Mahiou, R.
Maisonial-Besset, A.
Maunit, B.
MAZUEL, L.
Quintana, M.
Vivier, M.
MIOT-NOIRAULT, E.
Boyer, D.
Pokaż więcej
Temat :
[CHIM]Chemical Sciences
Źródło :
The SFNano – C’Nano joint meeting 2019
The SFNano – C’Nano joint meeting 2019, Dec 2019, Dijon, France
Tytuł :
Preliminary evaluations of PSMA-targeted NIR upconverting nanoparticles for dual scintigraphic/fluorescence-guided surgery in prostate cancer.
Autorzy :
CORDONNIER, A.
Chezal, J.-M.
Besse, S.
BRIAT, A.
Degoul, F.
Mahiou, R.
Maisonial-Besset, A.
Maunit, B.
MAZUEL, L.
Quintana, M.
Vivier, M.
MIOT-NOIRAULT, E.
Boyer, D.
Pokaż więcej
Temat :
[CHIM]Chemical Sciences
Źródło :
The SFNano – C’Nano joint meeting 2019
The SFNano – C’Nano joint meeting 2019, Dec 2019, Dijon, France
Tytuł :
Preliminary evaluations of PSMA-targeted NIR upconverting nanoparticles for dual scintigraphic/fluorescence-guided surgery in prostate cancer.
Autorzy :
CORDONNIER, A.
Chezal, J.-M.
Besse, S.
BRIAT, A.
Degoul, F.
Mahiou, R.
Maisonial-Besset, A.
Maunit, B.
MAZUEL, L.
Quintana, M.
Vivier, M.
MIOT-NOIRAULT, E.
Boyer, D.
Pokaż więcej
Temat :
[CHIM]Chemical Sciences
Źródło :
The SFNano – C’Nano joint meeting 2019
The SFNano – C’Nano joint meeting 2019, Dec 2019, Dijon, France
Tytuł :
Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms.
Autorzy :
Akil H; UMR 1240 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France. Electronic address: .
Rouanet J; UMR 1240 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France; Department of Dermatology and Oncodermatology, CHU Estaing, Clermont-Ferrand, France; Centre Jean Perrin, Clermont-Ferrand, France. Electronic address: .
Viallard C; UMR 1240 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France. Electronic address: .
Besse S; UMR 1240 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France. Electronic address: sophie.besse@inserm.fr.
Auzeloux P; UMR 1240 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France. Electronic address: .
Chezal JM; UMR 1240 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France. Electronic address: .
Miot-Noirault E; UMR 1240 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France. Electronic address: .
Quintana M; UMR 1240 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France. Electronic address: .
Degoul F; UMR 1240 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2019 Nov; Vol. 12 (11), pp. 1442-1452. Date of Electronic Publication: 2019 Aug 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Synthesis and preliminary biological evaluations of PSMA-targeted NIR upconverting nanoparticles for optical/scintigraphic imaging of prostate cancer.
Autorzy :
CORDONNIER, A.
Boyer, D.
Besse, S.
BRIAT, A.
Degoul, F.
Mahiou, R.
Maisonial-Besset, A.
Maunit, B.
MAZUEL, L.
Quintana, M.
Vivier, M.
MIOT-NOIRAULT, E.
CHEZAL, J-M.
Pokaż więcej
Temat :
[CHIM]Chemical Sciences
Źródło :
NanoMedicine International Conference (Nanomed 2019)
NanoMedicine International Conference (Nanomed 2019), Oct 2019, Lisbonne, Portugal
Tytuł :
Synthesis and preliminary biological evaluations of PSMA-targeted NIR upconverting nanoparticles for optical/scintigraphic imaging of prostate cancer.
Autorzy :
CORDONNIER, A.
Boyer, D.
Besse, S.
BRIAT, A.
Degoul, F.
Mahiou, R.
Maisonial-Besset, A.
Maunit, B.
MAZUEL, L.
Quintana, M.
Vivier, M.
MIOT-NOIRAULT, E.
CHEZAL, J-M.
Pokaż więcej
Temat :
[CHIM]Chemical Sciences
Źródło :
NanoMedicine International Conference (Nanomed 2019)
NanoMedicine International Conference (Nanomed 2019), Oct 2019, Lisbonne, Portugal
Tytuł :
Synthesis and preliminary biological evaluations of PSMA-targeted NIR upconverting nanoparticles for optical/scintigraphic imaging of prostate cancer.
Autorzy :
CORDONNIER, A.
Boyer, D.
Besse, S.
BRIAT, A.
Degoul, F.
Mahiou, R.
Maisonial-Besset, A.
Maunit, B.
MAZUEL, L.
Quintana, M.
Vivier, M.
MIOT-NOIRAULT, E.
CHEZAL, J-M.
Pokaż więcej
Temat :
[CHIM]Chemical Sciences
Źródło :
NanoMedicine International Conference (Nanomed 2019)
NanoMedicine International Conference (Nanomed 2019), Oct 2019, Lisbonne, Portugal
Tytuł :
TIP60 Inhibitor TH1834 Reduces Breast Cancer Progression in Xenografts in Mice.
Autorzy :
Idrissou M; Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France.; INSERM-UMR 1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France.
Judes G; Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France.; INSERM-UMR 1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France.
Daures M; Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France.; INSERM-UMR 1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France.
Sanchez A; Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France.; INSERM-UMR 1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France.
El Ouardi D; Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France.; INSERM-UMR 1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France.
Besse S; INSERM-UMR 1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France.
Degoul F; INSERM-UMR 1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France.
Penault-Llorca F; INSERM-UMR 1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France.; Department of Biopathology, Centre Jean Perrin, Clermont-Ferrand, France.
Bignon YJ; Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France.; INSERM-UMR 1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France.
Bernard-Gallon D; Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France.; INSERM-UMR 1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France.
Pokaż więcej
Źródło :
Omics : a journal of integrative biology [OMICS] 2019 Sep; Vol. 23 (9), pp. 457-459.
Typ publikacji :
Letter
MeSH Terms :
Antineoplastic Agents/*pharmacology
Enzyme Inhibitors/*pharmacology
Lysine Acetyltransferase 5/*antagonists & inhibitors
Animals ; Antineoplastic Agents/chemistry ; Breast Neoplasms/drug therapy ; Breast Neoplasms/pathology ; Disease Models, Animal ; Enzyme Inhibitors/chemistry ; Female ; Humans ; Mice ; Xenograft Model Antitumor Assays
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies